Of note, although these two models primarily focus on cancer cell apoptosis, their formulation also included several major angiogenesis‐related transcription factors (such as AP‐1, Myc, p53, FOXO), so that a systems‐level model‐based characterization of how cancer cells change their angiogenic potential under different conditions is feasible. The gene discussed is TP53; the disease is cancer.